The first clinical engineering (CE) benchmarking between Chinese and American hospitals was performed in 2014. At that time, only data from Zhejiang province were available. A new comparison was completed in 2018 with data collected from 11 hospitals from the capital city of Beijing. These data were compared with those from 270 acute care hospitals in the United States. First, comparisons were made with hospital data such as patient discharges, patient days, equipment quantity and cost, and operating costs. The CE benchmarking comparison was made in 3 categories: (a) operations, (b) finance, and (c) staffing/productivity. Within the operations category, the following metrics were compared: equipment amount/operating beds, annual repairs/equipment amount, and annual scheduled maintenance/equipment amount. Within the finance category, the following metrics were compared: total CE expense/total hospital operating expense, total CE expense/operating beds, and total CE expense/equipment cost. Within the staffing/productivity category, the following metrics were compared: total CE full-time equivalent (FTE)/equipment amount, total CE FTE/operating beds, and total CE FTE/total hospital operating expense. These comparisons showed the following: (1) Although still a bit lower than the United States, Beijing hospitals have more equipment than Zhejiang but a slightly lower amount of repairs and scheduled maintenance per equipment; (2) the total CE expense/total hospital operating expense ratio is around 1% in both Beijing and the United States, but slightly greater than in Zhejiang; however, the total CE expense/operating beds and total CE expense/equipment cost are still lower in Beijing and Zhejiang than in the United States; and (3) the CE FTE amount is lower in Beijing than in Zhejiang and closer to the United States relative to both equipment amount and total hospital operating expense, but still a bit lower than the United States relative to the number of operating beds. Some of the differences detected are likely caused by the same factors found in the previous study of Zhejiang hospitals, namely, higher length of stay in China than in the United States, lower wages and living costs in China, and different healthcare delivery methods in these countries. The differences found between Beijing and Zhejiang cannot be explained solely by inflation (~2%/year) or even higher cost of living in the capital but likely because of more equipment-intensive medical practice. Overall, these results confirm the outstanding progress and level of excellence of CE in China.